Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1985 | 1 |
1996 | 1 |
2007 | 1 |
2014 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
subsalicylate de bismuto
Your search for
subsalicilato-de-bismuto
retrieved no results
[Addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection: efficiency and adverse events].
Rev Gastroenterol Peru. 2014 Oct-Dec;34(4):315-20.
Rev Gastroenterol Peru. 2014.
PMID: 25594755
Clinical Trial.
Spanish.
OBJECTIVES: To establish the efficiency and adverse effects of the addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection. ...The study population consisted of 54 patients with Helicobacter pylori infection: 29 were allocat …
OBJECTIVES: To establish the efficiency and adverse effects of the addition of bismuth subsalicylate to triple eradication the …
[The high fermentative capacity of colonic bacteria in the origin of flatulence and its sensibility to bismuth subsalicylate].
León-Barúa R, Alvarez De Roig M, Roig-Arosemena J, Berendson-Seminario R, Torres-Zevallos H.
León-Barúa R, et al.
Rev Gastroenterol Peru. 2007 Jan-Mar;27(1):21-4.
Rev Gastroenterol Peru. 2007.
PMID: 17431432
Spanish.
Using a previously described technique, "in vitro" determinations were carried out for faecal fermentation (FF): basal faecal fermentation (BFF), i.e, only with faeces, with faeces and lactulose (LFF) and with faeces, lactulose and bismuth subsalicylate (BiLFF) in 34 patie …
Using a previously described technique, "in vitro" determinations were carried out for faecal fermentation (FF): basal faecal fermentation ( …
Item in Clipboard
[Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
Ramirez Mayans JA, Zamora Davila E, Cervantes Bustamante R, Mata Rivera N, Oyervides Garcia I, Cuevas S, Zarate Mondragón FE.
Ramirez Mayans JA, et al.
Acta Gastroenterol Latinoam. 1996;26(5):281-3.
Acta Gastroenterol Latinoam. 1996.
PMID: 9363265
Clinical Trial.
Spanish.
OBJECTIVE: Elimination of Helicobacter pylori with Chlaritromicin, Bismuth subsalicylate and Ranitidine; and improvement of recurrent abdominal pain. ...METHOD: 22 children with recurrent abdominal pain associated to gastritis and histologic identification of Helicobacter …
OBJECTIVE: Elimination of Helicobacter pylori with Chlaritromicin, Bismuth subsalicylate and Ranitidine; and improvement of recurrent …
Item in Clipboard
[In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
León-Barúa R, Tello-Casanova R.
León-Barúa R, et al.
Acta Gastroenterol Latinoam. 1985;15(3):157-64.
Acta Gastroenterol Latinoam. 1985.
PMID: 3836544
Spanish.
An investigation was done on the action in vitro of two pharmaceutical preparations containing Bi, De Nol and Pepto Bismol, on the fermentative capacity of intestinal bacteria. ...In 11 of the samples, FF was measured without and with addition of De Nol; and in the …
An investigation was done on the action in vitro of two pharmaceutical preparations containing Bi, De Nol and Pepto Bismol, on the fe …
Item in Clipboard
Cite
Cite